Listed Launchpad SKU
On the Launchpad contract
Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.
Longevity · Launchpad care path
NAD+ — cellular energy support on the partner care path.
NAD+ (NAD) is on the partner Launchpad contract. Livozo is the brand and marketing site; when care goes live, our clinical partner hosts intake and their clinicians decide whether NAD+ is appropriate. Compounded NAD+ is not FDA-approved. This page is coming soon — not live care today.
At a glance
What this page is built to clarify.
Listed Launchpad SKU
Partner clinician review
Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.
Listed Launchpad SKU
Licensed sourcing only
Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.
Clinical context
How to read this page.
These pages describe possible pathways, not a promise that any medication will be prescribed, shipped this week, or available in any state today. Livozo does not employ the prescriber. After Launchpad go-live, the clinical target is 50-state coverage via licensed partner clinicians. Louisiana blocks shipping of compounded GLP-1s.
Compounded NAD+ is not FDA-approved. Suitability, route, and dose are partner clinician decisions. FDA has issued alerts about sterile injectables generally — sourcing and pharmacy quality matter.
- Low energy or fatigue
- Focus and recovery goals
- Healthy-aging interest
- Interest in supervised wellness injectables
Partner model
What the partner path can include later.
When Launchpad is wired
- Partner-hosted medical and medication intake
- Licensed partner clinician review of suitability
- Dosing and administration guidance from the partner if prescribed
- Partner portal follow-up — Livozo does not run the clinic
Potential options
- Compounded NAD+ when a partner clinician prescribes
- B12 is a separate Launchpad path when appropriate
Exact medication, formulation, quantity, refill timing, and pharmacy routing depend on the clinical partner, applicable law, and clinical appropriateness. The partner's licensed 503A pharmacy network — not an exclusive Red Rock claim — fulfills partner prescriptions if written. None of that is live today.
Next step
Coming soon — not a live clinic, enrollment, or prescription.
This is a Launchpad catalog listing under a coming-soon posture, not live clinician care. When Launchpad is wired, a marketing CTA will hand off to partner intake. Until then there is no enrollment, start-visit, or checkout path. No prescription, charge, or shipment happens from this site.